Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 2/3 1

Status

Recruiting 4Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 7

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Androgen Antagonists 3Radiosurgery 2zimberelimab 1quemliclustat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Oligometastatic Prostate Cancer × Clear all
NCT04610372 2026-05-06

PROMPT

British Columbia Cancer Agency

Phase NA Recruiting
168 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT07490210 2026-03-24

OMPC-RPM

Fudan University

Phase 2 Not yet recruiting
300 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT05560659 2025-07-11

POPSTAR II

Peter MacCallum Cancer Centre, Australia

Phase 2 Recruiting
92 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT05915442 2025-05-20

SBRT-AMICO

Columbia University

Phase 2 Recruiting
23 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT06972511 2025-05-15

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

RenJi Hospital

Phase 2/3 Recruiting
120 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT06060652 2023-09-29

PROMETEO

Centro di Riferimento Oncologico - Aviano

Unknown
104 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT03940235 2023-06-28

RADIOSA

European Institute of Oncology

Phase 2 Unknown
150 enrolled
Genitourinary

Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡